[go: up one dir, main page]

CH269654A - Process for the preparation of a basic thioether. - Google Patents

Process for the preparation of a basic thioether.

Info

Publication number
CH269654A
CH269654A CH269654DA CH269654A CH 269654 A CH269654 A CH 269654A CH 269654D A CH269654D A CH 269654DA CH 269654 A CH269654 A CH 269654A
Authority
CH
Switzerland
Prior art keywords
preparation
piperidino
basic
chloride
formula
Prior art date
Application number
Other languages
German (de)
Inventor
Podnik Spojene Farmace Narodni
Original Assignee
Spojene Farmaceuticke Z Narodn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spojene Farmaceuticke Z Narodn filed Critical Spojene Farmaceuticke Z Narodn
Publication of CH269654A publication Critical patent/CH269654A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

  <B>Verfahren zur Darstellung eines</B>     basischen        Thioäthers.       Es ist aus der pharmakologischen Litera  tur bekannt, dass in     physiologisch    wirksamen  Substanzen der Ersatz von Sauerstoff durch  Schwefel zu therapeutisch interessanten Ver  bindungen führt (R. 0.     Roblin        jr.        Chem.     Review, 35, 255 [19461). Manchmal wird nur  eine quantitative Änderung der Wirksamkeit  erreicht; es sind aber auch bereits Fälle be  kannt, wo durch den Austausch der gebann  ten Elemente sogar pharmakologische Anta  gonisten erhalten werden.  



  Bisher fehlen Veröffentlichungen über die       Antihistaminwirkung    von basischen     Äthern,     welche im Molekül Schwefel enthalten. Bei  der Darstellung einiger solcher Verbindungen  wurde überraschend festgestellt, dass sie bei       unveränderter        Antihistaminwirkung    eine er  heblich geringere Toxizität aufweisen als die       entsprechenden    Sauerstoffverbindungen und  daher therapeutisch besonders wertvoll sind.  



  Es wurde gefunden, dass basische     Aralkyl-          thioäther    der allgemeinen Formel:  
EMI0001.0014     
    wobei X = Wasserstoff oder eine     Phenyl-          gruppe    und     NR,    = den Rest eines zyklischen  sekundären Amins bedeuten, hergestellt wer  den können durch die Kondensation eines       Mercaptans    der Formel I mit einem     hetero-          cyclischen    sekundären Amin der Formel     1I,     und zwar durch die Reaktion des Natrium-         derivates    des     Mercaptans    mit dem Chlorid des  sekundären Amins.

    
EMI0001.0024     
    oder durch die Reaktion des     Natriumderiva-          tes    eines     Mercaptans    der Formel     III    mit  einem Chlorid der Formel IV.  
EMI0001.0029     
    Gegenstand vorliegender Erfindung ist ein  Verfahren zur Darstellung des     Diphenyl-          methyl    -     ss    -     piperidino    -     äthylthioäthers,    welches  dadurch gekennzeichnet ist,

   dass das     Natritun-          derivat    des     ss-Piperidino-äthylmercaptans    mit       Diphenylmethylchlorid    kondensiert wird. Das  erhaltene Endprodukt bildet farblose Kristalle  mit einem Schmelzpunkt von 176 bis 177  C       (unkorrigiert).    Es ist in Wasser leicht lös  lich.  



       Beispiel:     2,3 g Natrium (0,1     Mol)    wurden in  100     cmg    absolutem Äthanol aufgelöst und all  mählich 13,3 g (0,1     Mol)        fl-Piperidino-äthyl-          mercaptan    zugesetzt. Zum Reaktionsgut wur  den tropfenweise 20 g     Diphenylmethylchlorid     hinzugefügt, das Ganze 12 Stunden bei  Raumtemperatur     stehengelassen    und sodann  während 3 Stunden am     Rüekflusskühler    zum      Sieden erhitzt.

   Nach     dein    Erkalten wurde das  ausgeschiedene Chlornatrium     abfiltriert.    Das  Filtrat wurde mit 500     eins    absolutem Äther       verdünnt,    blank filtriert und tropfenweise  mit der berechneten Menge von alkoholischer  Salzsäure versetzt. Das ausgefällte Kondensa  tionsprodukt wurde     abfiltriert    und aus     Iso-          propanol    umkristallisiert.

   Die Analyse bestä-         tigte    die Bruttoformel     C"oH"NSCl    des     Hy-          drochlorids    des     Diphenylmethyl-fl-piperidino-          äthylthioäthers,    eine Substanz in Gestalt von  farblosen Kristallen vom     Schmp.    176 bis  177 C (nichtkorrigiert), welche in Wasser  leicht löslich ist.  



  Das erhaltene Produkt entspricht der  Strukturformel  
EMI0002.0015     
    und ist eine neue Verbindung, welche sich  klinisch bewährt hat als     untoxisches        Anti-          histaminicum    von hoher Wirksamkeit.



  <B> Method for the preparation of </B> a basic thioether. It is known from the pharmacological literature that the replacement of oxygen by sulfur in physiologically active substances leads to therapeutically interesting compounds (R. 0. Roblin Jr. Chem. Review, 35, 255 [19461). Sometimes only a quantitative change in effectiveness is achieved; but there are also already known cases where even pharmacological antagonists are obtained by exchanging the banned elements.



  So far there have been no publications on the antihistamine effect of basic ethers which contain sulfur in the molecule. In the presentation of some such compounds, it was surprisingly found that, with unchanged antihistamine action, they have a considerably lower toxicity than the corresponding oxygen compounds and are therefore of particular therapeutic value.



  It has been found that basic aralkyl thioethers of the general formula:
EMI0001.0014
    where X = hydrogen or a phenyl group and NR = the radical of a cyclic secondary amine mean, who can be prepared by the condensation of a mercaptan of the formula I with a heterocyclic secondary amine of the formula 1I, by the reaction of the Sodium derivatives of the mercaptan with the chloride of the secondary amine.

    
EMI0001.0024
    or by the reaction of the sodium derivative of a mercaptan of the formula III with a chloride of the formula IV.
EMI0001.0029
    The present invention is a process for the preparation of diphenylmethyl - ss - piperidino - ethylthioether, which is characterized by

   that the sodium derivative of β-piperidino-ethyl mercaptan is condensed with diphenylmethyl chloride. The end product obtained forms colorless crystals with a melting point of 176 to 177 C (uncorrected). It is easily soluble in water.



       Example: 2.3 g of sodium (0.1 mol) were dissolved in 100 cmg of absolute ethanol and gradually 13.3 g (0.1 mol) of fl-piperidino-ethyl-mercaptan were added. 20 g of diphenylmethyl chloride were added dropwise to the reaction mixture, the whole was left to stand for 12 hours at room temperature and then heated to boiling for 3 hours on a reflux condenser.

   After cooling down, the precipitated sodium chloride was filtered off. The filtrate was diluted with 500 units of absolute ether, filtered until it was clear and the calculated amount of alcoholic hydrochloric acid was added dropwise. The precipitated condensation product was filtered off and recrystallized from isopropanol.

   The analysis confirmed the gross formula C "oH" NSCl of the hydrochloride of diphenylmethyl-fl-piperidinoethylthioether, a substance in the form of colorless crystals with a melting point of 176 to 177 ° C. (uncorrected) which is easily soluble in water.



  The product obtained corresponds to the structural formula
EMI0002.0015
    and is a new compound which has proven itself clinically as a non-toxic antihistamine of high effectiveness.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Darstellung des Diphenyl, inethyl fB-piperidino-äthylthioäthers, dadurch gekennzeichnet, dass das Natriumderivat des fl-Piperidino-äthylmercaptans mit Diphenyl- methylchlorid kondensiert wird. Das erhaltene Endprodukt bildet farblose Kristalle mit einem Schmelzpunkt von 176 bis 177 C (un- korrigiert). Es ist in Wasser leicht löslich. PATENT CLAIM: Process for the preparation of diphenyl, methyl fB-piperidino-ethylthioether, characterized in that the sodium derivative of fl-piperidino-ethyl mercaptan is condensed with diphenylmethyl chloride. The end product obtained forms colorless crystals with a melting point of 176 to 177 C (uncorrected). It is easily soluble in water. UNTERANSPRUCH: Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass die Kondensation in ab solut alkoholischer Lösung zuerst bei Zimmer temperatur und später durch Erhitzen am Rückflusskühler auf den Siedepunkt des Lö sungsmittels vervollständigt wird. SUBSTANTIAL CLAIM: Method according to patent claim, characterized in that the condensation in absolute alcoholic solution is completed first at room temperature and later by heating on the reflux condenser to the boiling point of the solvent.
CH269654D 1947-07-01 1948-06-28 Process for the preparation of a basic thioether. CH269654A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS269654X 1947-07-01

Publications (1)

Publication Number Publication Date
CH269654A true CH269654A (en) 1950-07-15

Family

ID=5451709

Family Applications (1)

Application Number Title Priority Date Filing Date
CH269654D CH269654A (en) 1947-07-01 1948-06-28 Process for the preparation of a basic thioether.

Country Status (1)

Country Link
CH (1) CH269654A (en)

Similar Documents

Publication Publication Date Title
DE1670849B2 (en) PROCESS FOR THE PREPARATION OF 8-ACYLAMINO-1,2,3,4-TETRAHYDROISOCHINOLINES
DE2938302A1 (en) NEW DERIVATIVES OF 3- (AMINOAETHYL) - PHENOLS AND THEIR SALTS, THEIR PRODUCTION PROCESS, THEIR USE AS A MEDICINAL PRODUCT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE1545575C2 (en) N, N&#39;-Bis- square bracket to 3 &#34;(3 &#39;, 4&#39;, 5&#39;-trimethoxybenzoyloxy) -propyl square bracket to -homopiperazine
DE1445186B2 (en) 3,3&#39;-di-2-imidazolin-2-yl-carbanilide
CH622491A5 (en) Process for the preparation of novel hydroxypropylamines
DE1154119B (en) Process for the preparation of 2- (2 &#39;, 4&#39;, 6&#39;-trimethylbenzyl) -1, 3-diazacyclopentene- (2) and its salts
DE949742C (en) Process for the preparation of N-allyl normorphine from normorphine and allyl halide
CH269654A (en) Process for the preparation of a basic thioether.
DE2144077C3 (en) New Hydroxyäthylaminoalkylpiperazines and processes for their preparation
DE2166270C3 (en) Nicotinoylaminoethanesulfonyl-2amino-thiazole
DE1952800C3 (en) 3,6-dimethyl-1,2,3,4,4a, 9a-hexahydro-gamma-carboline dihydrochloride
DE829894C (en) Process for the preparation of new derivatives of 1,8-naphthyridine-4-carboxylic acids
DE1670143C3 (en)
DE837534C (en) Process for the preparation of pyridinium compounds
AT251585B (en) Process for the preparation of new 6,7-dihydro-5H-pyrrolo- [3,4-d] -pyrimidines
DE896047C (en) Process for the preparation of salicylic acid derivatives
DE1182237B (en) Process for the preparation of 10- [4&#39;-hydroxy-4&#39;-hydroxyalkylpiperidinoalkyl] -phenthiazine derivatives
AT278808B (en) Process for the preparation of new 4-acyl-3,4-dihydro-2 (1H) -quinoxalinone derivatives
AT211302B (en) Process for the preparation of new monoalkylaminopropionyl toluidides and their salts
AT282593B (en) PROCESS FOR THE PREPARATION OF NEW RACEMIC OR OPTICALLY ACTIVE (1-2&#39;-NITRILOPHENOXY) -2-HYDROXY-3-ISOPROPYLAMINOPROPANE AND ITS SALTS
AT265530B (en) Process for the preparation of new isoquinoline derivatives
AT237597B (en) Process for the production of new propylamine derivatives and their salts
DE2538593C3 (en) m-Trifluoromethylthio-phenethylamine derivatives, process for their preparation and pharmaceuticals containing these compounds
DE920546C (en) Process for the preparation of derivatives of 3- (4&#39;-oxyphenyl) -3- (4 &#34;-oxy-3&#34; -aminomethyl-phenyl) -oxindole
DE1024968B (en) Process for the preparation of 7-ketonyl-8-amino-theophyllines